[Federal Register: February 8, 2006 (Volume 71, Number 26)]
[Notices]
[Page 6501]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08fe06-109]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Portfolio Review of Hereditary Blood Disorders

    In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting:
    Name: Disease, Disability, and Injury Prevention and Control
Special Emphasis Panel (SEP): Portfolio Review of Hereditary Blood
Disorders.
    Times and Dates: 9:30 a.m.-5 p.m., March 2, 2006 (Closed). 9 a.m.-4
p.m., March 3, 2006 (Closed).
    Place: National Center on Birth Defects and Developmental
Disabilities, CDC, 12 Executive Park Drive, Atlanta, GA 30329,
Telephone Number 404.498.3800.
    Status: The meeting will be closed to the public in accordance with
provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review and
discussion of the Hereditary Blood Disorders Division's strategies and
activities.
    For Further Information Contact: Esther Sumartojo, Acting Associate
Director for Science and Public Health, National Center on Birth
Defects and Developmental Disabilities, CDC, 1600 Clifton Road, NE.,
Mailstop E-87, Atlanta, GA 30333, Telephone Number 404.498.3800.
    The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: February 2, 2006.
Diane Allen,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
 [FR Doc. E6-1677 Filed 2-7-06; 8:45 am]

BILLING CODE 4163-18-P